ATRC - Company ID 0001323885
The table below shows AtriCure, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $141.25M | $134.27M | $136.14M | $123.62M | $115.91M | $116.27M |
| Cost of revenue | $31.94M | $32.94M | $34.66M | $30.99M | $29.12M | $29.43M |
| Gross profit | $109.31M | $101.33M | $101.48M | $92.63M | $86.79M | $86.84M |
| R&D | $24.23M | $22.89M | $29.28M | $22.53M | $20.96M | $20.42M |
AtriCure, Inc. reported annual revenue of $534.53M for fiscal year 2025. That is up 14.9% from $465.31M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $155.11M (FY 2016) to $534.53M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $84.55M | $78.23M | $78.39M | $76.05M | $73.24M | $73.60M |
| Operating income | $526.00K | $208.00K | -$6.19M | -$5.95M | -$7.41M | -$7.17M |
| Income tax | $286.00K | $181.00K | $261.00K | $239.00K | $322.00K | $253.00K |
| Net income | $108.00K | -$267.00K | -$6.19M | -$6.75M | -$7.85M | -$8.01M |
| EPS (diluted) | $0.00 | -$0.01 | -$0.13 | -$0.14 | -$0.17 | -$0.17 |